The U.S. Food and Drug Administration said Thursday it was investigating the possibility of an increased risk of mood changes and suicidal behavior among those who take the highly popular asthma drug Singulair.
Singulair is the number one-selling drug among people aged 17 and younger. Last year, it posted…
The Food and Drug Administration has issued an “early communication” to health care professionals regarding its review of the postmarketing reports it has received of behavior/mood changes, suicidality, and suicide in patients who have taken the asthma and allergy medication montelukast (Singulair).
At press time, the agency had declined to say how many repo…
Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007; 175: 323-329.
* Clinical question
Does montelukast …
1. Practice breathing from the diaphragm or abdomen instead of the chest. When you are breathing correctly the belly will push outward on breathing in, and contract or tighten when breathing out. The chest and shoulders do not rise up.
2. If you do start wheezing or getting short of br…
Top 10 Pharmaceutical Product Web Sites Visited by Physicians
1. Pfizer’s Lipitor
2. Merck’s Fosamax
3. Shire’s Adderall XR
4. GlaxoSmithKline’s Advair
5. Bristol-Myers Squibb and Sanofi-Aventis’ Plavix
6….
